adjuvants, such as dexrazoxane 4 and vitamin C, 5 were co-administered to boost chemotherapeutic efficacy with the purpose of suppressing cardiotoxicity. 6 Nevertheless, limited evidence supports
| INTRODUC TI ON
Doxorubicin (DOX), an effective anthracycline, is a chemotherapeutic drug commonly used to treat a wide range of cancers. However, its use is limited due to the potential risk of cardiotoxicity. 1 Increased mortality associated with the total accumulated dose of DOX has been shown in chemotherapy cycles. 2 Under this circumstance, researchers have considered designing DOX analogues with reduced acute toxicity; however, this has been confounded by a paralleled loss of anti-cancer efficacy. 3 On the contrary, cardioprotective the cardioprotective effects of these natural compounds and synthetic drugs against DOX-induced cardiotoxicity. 7, 8 There has been growing interest in the possible benefits of polyphenols due to their antioxidant as well as anti-apoptotic properties. 9 Emerging evidence has demonstrated that polyphenols can prevent DOX-induced cardiotoxicity by exerting their anti-cancer and cardioprotective effects. 10 We previously investigated the beneficial effects of yellow wine, which is full of polyphenols, and found that yellow wine polyphenolic compounds (YWPC) could delay the development of atherosclerosis. 11, 12 However, whether YWPC inhibit DOX-induced cardiotoxicity remains unclear.
To date, multiple molecular mechanisms have been indicated in DOX-induced cardiotoxicity, and oxidative stress is believed to play a central role, 1, 13 as witnessed by reactive oxygen species (ROS)-induced injury, including lipid peroxidation and reduced levels of endogenous antioxidant defences. 14 Oxidative stress also induced activation of several pro-fibrogenic factors to the subsequent extracellular matrix (ECM) accumulation, leading to the development of cardiac fibrosis. 15 Therefore, understanding how the oxidant-antioxidant balance is related to the control of oxidative stress may provide insights into effective therapies for DOX-induced cytotoxicity. To control oxidative homoeostasis, cells are equipped with an efficient defence system against oxidants. A plenty of studies have identified that nuclear factor-E2-related factor-2 (Nrf2) is implicated as a master regulator in the cellular response to oxidative stress. 16 Moreover, emerging evidence suggests the importance of inflammation in the pathogenesis of DOX-induced cardiotoxicity 17, 18 and Nrf2 also has an anti-inflammatory effect. 19 Although several studies have revealed that the deactivation of Nrf2 signalling was involved in DOX-induced cardiotoxicity, 17, 20 whether Nrf2 activation could help to alleviate DOX-induced cardiac fibrosis are rarely studied. 21 In this study, we hypothesized that YWPC could ameliorate DOX-induced cardiotoxicity by inhibiting oxidative stress-induced cell apoptosis and oxidative stress-mediated ECM accumulation.
To reveal the mechanisms underlying the action of YWPC, we also examined whether YWPC could suppress DOX-induced oxidative stress through the regulation of Nrf2 signalling pathway.
| MATERIAL S AND ME THODS

| Animals and treatments
All procedures in this study were performed according to the Guide (E) WGA staining of left ventricular tissue from rats described in A for determination of cardiac and cardiac myocyte hypertrophy (Bar = 100 μm, n = 10). *P < 0. Figure 1A .
YWPC in dry powder form from yellow rice wine were provided
by National Engineering and Research Center for traditional Chinese medicine (Shanghai, China). The procedures used to prepare and analyse YWPC have been described previously. 12 According to the Food and Drug Administration (FDA) standard for drinking alcohol at a rate of 12-24 g per day, drinking 200 mL of Shaoxing rice wine with an alcohol content of 12% per day is appropriate. The polyphenol content of Shaoxing rice wine is about 1 mg/mL, so the daily intake of rice wine polyphenols is about 200 mg. According to 70 kg body weight, the intake of rice wine polyphenols is about 2.86 mg/ kg. According to the coefficient of 9.1, the weight of 200-250 g rat polyphenol intervention medium dose is about 30 mg/kg, which was chosen as the appropriate dose for polyphenol intervention in this study.
| Transthoracic echocardiography and electrocardiograph recordings
Cardiac echocardiography was performed with the Philips iE33 system (Philips Medical, Best, Netherlands) equipped with an s5-1 probe (12-14 MHz) to measure parameters, including left ventricular (LV) ejection fraction (LVEF), LV fractional shortening (LVFS), LV internal dimension-systole (LVIDs) and LV internal dimension-diastole (LVIDd). Heart rate was also recorded through the electrocardiograph signal. Philips QLab 9 post-processing software was used for data analysis.
| Histological assessment of myocardial injury and collagen content
After treatment for 4 weeks, all rats were anaesthetized to remove the heart. The heart was quickly photographed and followed by dissecting into small portions and immediately snap-frozen in liquid nitrogen until analysis. Part of the heart was fixed in 10% formalin, embedded in paraffin, and sectioned at 5-μm thickness.
Haematoxylin and eosin (H&E) staining was used to evaluate the general morphology of the myocardium. The sections were imaged using the Leica DM3000 biological microscope (Leica, Wetzlar, Germany) at 200× magnification. For collagen analysis, the heart sections underwent Masson's trichrome staining. Collagen deposition was quantified using Image-ProPlus6 (Media Cybernetics, Rockville) as previously described. 27 
| Immunohistochemistry
Sections were stained with primary antibodies against TGF-β1 
| Measurement of TNF-β1, IL-1β and IL-6
Heart tissues were lysed with protein lysis buffer, and the lysates were subject to determine the levels of pro-inflammatory cytokines (TNF-β1, IL-1β and IL-6) using ELISA Kits (Qiagen, Inc, Hilden, Germany), according to the manufacturer's instructions. Optical densities were measured using a SpectraMax Plus Absorbance microplate reader (Molecular devices, CA) at 450 nm.
| Transmission electron microscopy
A portion of the left ventricle was from each rat cut into 1 mm fragments and was fixed in 2.5% glutaraldehyde overnight for electron microscopic examination. The tissues were fixed in 1% osmic acid followed by dehydrated in a series of acetone washes. The tissues were then embedded in Araldite for coronal sections and sectioned at 1 μm. The slides were stained with toluidine blue and ultra-thin sections were cut in from this block and were observed under a
Cs-corrected TEM with Monochromator (Titan G2 60-300, FEI, Hillsboro).
| Apoptosis assay
An in situ cell death detection kit, POD (Roche Co. Ltd., Basel, Switzerland), was used to detect DNA fragmentation of individual cells. Paraffin-embedded sections of the heart tissues were deparaffinized with xylene and rehydrated in a graded ethanol series. The sections were incubated with proteinase K at 37°C for 20 minutes.
Tissues then were incubated with the TdT-mediated dUTP nick end labeling (TUNEL) reaction mixture at 37°C for 1 hour in the dark.
Subsequently, the sections were covered with converter-POD at 37°C for 30 minutes, followed by incubation with DAB for 3 minutes. After counterstaining with the nuclear counterstain hematoxylin for 30 seconds, the number of TUNEL-positive cells was counted with a Leica microscope at 100× magnification.
| Immunofluorescence
Frozen tissue sections were used for immunofluorescence assay to visualize the expression of caspase 3. Briefly, the cryostat sections were thawed at room temperature for 20 minutes and followed by incubation in blocking buffer (4% BSA) for 30 minutes. Subsequently, immunostaining was performed with an anti-caspase 3 antibody (ab32351, Abcam) and an Alexa Fluor 594 WGA (Life Technologies).
Nuclei were counterstained with 0.1 μg/mL DAPI (Sigma-Aldrich; D9564). Images were captured using a Nikon Eclipse Ti-U fluorescence microscope at ×400 magnification. 
| Cell culture and treatment
| Western blot analysis
Total protein was extracted from stored frozen tissues using RIPA lysis buffer (Beyotime) containing phosphatase inhibitor cocktail II (MedChem Express, China), and 30 μg of protein was separated by
SDS-PAGE and transferred to PVDF membranes (Millipore, MA).
The membranes were then blocked with 5% skim milk for 1 hour at room temperature and hybridized with primary antibodies against 
| Real-time reverse-transcription PCR
Total RNA was isolated from hearts tissues using TRIzol reagent (Invitrogen) following the manufacturer's protocol. RNA was reverse-transcribed with oligo (dT) primers and real-time PCR was conducted on an ABI 7300 RT-PCR Detection System (Applied Biosystems, Foster, CA) with gene-specific primers in the presence of SYBR Premix Ex Taq (TaKaRa). RT-qPCR was performed in triplicate. Relative fold changes in the expression of the target gene were determined using the 2 −△△CT method. 31 The primer sequences used were: HO-1 forward, 5′-CGGGCCAGCAACAAAGTG-3′ and reverse, 5′-CGGGCCAGCAACAAAGTG-3′; NQO-1 forward, 5′-TTCCGGAG TAAGAAGGCAGT-3′ and reverse, 5′-GAAGCCACAGAAATGCAGAA-3′;
GCLM forward, 5′-ATGGAGTTCCCAAATCAGCC-3′ and reverse, 5′-ATT GGGTTTTACCTGTGCCC-3′; GAPDH forward, 5′-GCACCGTCAAG GCTGAGAAC-3′ and reverse, 5′-TGGTGAAGACGCCAGTGGA-3′.
| Assessment of mitochondrial membrane potential
JC-1 method was used to measure mitochondrial membrane potential as described previously. 32 In brief, following treatment, H9C2 
| Statistical analysis
Results are shown as mean ± standard deviation (SD). Differences among groups were analysed using one-way ANOVA, followed by Tukey's post hoc analysis. Data were analysed with the SPSS version 20.0 software (SPSS Inc, Chicago, IL). P < 0.05 was considered statistically significant.
| RE SULTS
| YWPC improve DOX-induced cardiac hypertrophy
As shown in Figure 1B , body weight gain was significantly decreased in the DOX group as compared to the control group.
However, co-administration of DOX and YWPC could reverse this trend. At the fourth week, the heart weight/body weight was higher in the DOX group than in the DOX + YWPC and control groups ( Figure 1C ). The global appearance of the heart in the indicated four groups has been shown in Figure 1D . The rats in the DOX group had an enlarged heart, whereas the remaining rats in the other three groups had similar normal heart. H&E staining Interestingly, in rats that were co-treated with YWPC, the normal myocardial architecture was preserved and cell injury significantly reduced ( Figure 1E ). Further, we found that DOX-associated enlargement in cardiomyocyte size was attenuated in YWPC-treated rats as assessed by WGA staining ( Figure 1F ). Collectively, these Cardiac antioxidant enzyme activities of (B) MDA, (C) SOD and (D) catalase were evaluated using in the heart homogenates from indicated groups. Enzyme-linked immunosorbent assay (ELISA) was used on serum from rats to determine the expression of transforming growth factor-β1 (TGF-β1) (E), interleukin-1β (IL-1β) (F), and interleukin-6 (IL-6) (G). Data are shown as the mean ± standard deviation of 10 rats. *P < 0.05, vs. the control; # P < 0.05 vs. the DOX group. DOX, doxorubicin; MDA, malondialdehyde; SOD, Superoxide Dismutase; YWPC, Yellow Wine Polyphenolic
Compounds results revealed that YWPC exhibit an effective protective role in DOX-induced cardiac hypertrophy.
| YWPC improve DOX-induced cardiac dysfunction
Echocardiography was then used to monitor the improvement in cardiac function (Figure 2A) . Results suggested that LVEF ( Figure 2B) and LVFS ( Figure 2C ) were similar in the YWPC and control groups, but significantly reduced in the DOX group, which was then enhanced by YWPC treatment. Compared to control group, DOX treatment markedly increased LVIDs ( Figure 2D ) and LVIDd ( Figure 2E ), which were ameliorated by YWPC treatment. However, the results of electrocardiography showed no significant difference in heart rate between the groups ( Figure 2F ).
| YWPC prevent DOX-induced oxidative stress, in vivo
To further understand the molecular mechanisms associated with the beneficial effects of YWPC, the levels of oxidative stress and endogenous antioxidant enzyme activities in the cardiac tissue were measured. As shown in Figure 3A , DHE staining showed increased number of DHE-positive cells in the DOX group, indicating the generation of ROS. YWPC effectively reduced the DOX-induced generation of ROS. In addition, high levels of lipid peroxidation production MDA were observed in DOX-stimulated rats, which were significantly decreased with the treatment of YWPC ( Figure 3B ).
Subsequently, a significant decrease in the activity of antioxidant enzymes, including SOD and catalase was observed in DOX-treated rats as compared to control and YWPC-treated rats ( Figure 3C and 3D). YWPC intake dramatically alleviated the reduction in antioxidant enzyme activity in the DOX + YWPC group. Furthermore, the levels of pro-inflammatory cytokines, TNF-β1, IL-1β, and IL-6 were significantly increased in the DOX group compared with the control and YWPC groups; however, their levels were reduced in the DOX + YWPC group compared to the DOX group ( Figure 3E-G) .
These results indicated that YWPC significantly alleviated DOX-induced oxidative damage through modulating the balance of oxidation and antioxidation.
| YWPC attenuate DOX-induced myocardial apoptosis
Because apoptosis plays a key role in DOX-associated cardiotoxicity, we thus explored the effects of YWPC on DOX-induced cell 
| YWPC attenuate DOX-induced reactive oxygen species (ROS) and down-regulation of transforming growth factor beta (TGF-β)/smad3 pathway dependent on Nrf2 status
ROS scavenging is a powerful way to protect against DOX-induced cardiac damage. 33 To explore the molecular mechanisms underlying the antioxidant effects of YWPC, we examined the effect of YWPC on the intracellular ROS level of (5 μmol/L for 24 hours) DOX-stimulated H9C2 cells using DCFDA. As illustrated in Figure 6A , treatment with 50 mg/L YWPC suppressed the intracellular ROS production of H9C2 cells, which triggered by DOX. A large number of studies have manifested the critical role of TGF-β1/smad3 signalling pathway in cardiac fibrosis. Using antibodies that recognize the unphosphorylated and phosphorylated form of smad3, we found that phosphorylation of smad3 induced by DOX was significantly attenuated in the presence of YWPC ( Figure 6B ). In addition, due to the critical role of Nrf2 in regulation of oxidative stress, we subsequently explored whether YWPC were involved in the regulation of Nrf2 expression.
Intriguing, when compared to the control group, 6 hours of DOX treatment notably up-regulated the cytosol expression levels of Nrf2, while down-regulated its nucleus levels. As expected, YWPC treatment obviously promoted Nrf2 translocation from cytoplasm to antioxidant genes ( Figure 6E-G) . Importantly, we found that YWPC reduced the DOX-induced TGF-β1 levels in the culture supernatants of H9C2 cells. CDDO-EA treatment further decreased TGF-β1 levels while Nrf2 silencing increased TGF-β1 levels ( Figure 6H ). In summary, these data indicated that YWPC attenuate DOX-induced ROS via TGF-β1/smad3 pathway in a Nrf2 dependent manner.
| YWPC alleviate DOX-induced cardiac fibrosis, in vivo
To validate the anti-fibrosis effects of YWPC, we then measured the changes of fibrotic proteins in DOX-injected rats with or without YWPC or CDDO-EA treatment. As shown in Figure 7A , C, the results of Masson's trichrome staining showed that compared with control group, the collagen content in the heart tissues of DOXtreated rats was increased, which was then significantly reduced by YWPC or CDDO-EA treatment. In addition, the pro-fibrotic factor TGF-β1, the ECM content collagen I and the cardiac fibrosis-associated protein α-SMA were remarkably increased in DOX-treated rats compared to those in control group, as detected by IHC. However, the levels of TGF-β1, Collagen I and α-SMA were reduced by the addition of YWPC or CDDO-EA ( Figure 7B, D) . Western blot analysis then showed that DOX significantly increased p-smad3 expression, which was reduced by YWPC or CDDO-EA treatment ( Figure 7E ).
Above Generally, Figure 8 showed the protective effects and potential mechanisms of YWPC on DOX-induced cardiotoxicity.
| D ISCUSS I ON
In this study, we demonstrated that YWPC effectively alleviated YWPC used in our study were derived from Shaoxing rice wine and have been identified owning the cardiovascular protective effects through inhibiting matrix metalloproteinase-2, -9 expression during atherogenesis. 11, 12, 34 The main mechanisms by which polyphenols are cardioprotective are related to the improvement of vascular function and their anti-atherogenic effect. 35 Of note, the use of polyphenols is currently being investigated as a possible adjunctive therapy in combination with DOX to protect the myocardium from DOX-induced oxidative stress. 36 DOX accumulates in the mitochondria and disrupts the mitochondria electron chain resulting in an enhanced production of ROS. 37 This enhanced production of reactive radicals can react with proteins, lipids and DNA molecules, causing DNA damage and lipid peroxidation. 38, 39 Oxidative stress through increased generation of ROS and compromised antioxidant defence are well documented in DOX-related myocardial apoptosis. 5, 40 Consistent with previous studies, 41 we found DOX treatment markedly induced ROS generation and reduced the activity of endogenous antioxidant enzymes, such as SOD and catalase in the heart tissues. This DOX-induced oxidative stress in the heart could be attenuated by 30 mg/kg YWPC treatment, which may be largely due to the antioxidant properties of polyphenols. 7 Currently, there are plenty of polyphenol monomers identified have the cardioprotective effects of DOX-induced cardiotoxicity because of their antioxidative effects. For instance, resveratrol has the ability to ameliorate DOXinduced myocardial structure damage and cardiac dysfunction in rats through inhibiting free radical generation, improving mitochondrial dysfunction and suppressing apoptosis. 42 Epigallocatechin-3-gallate possesses cardioprotective action against DOX by suppressing oxidative stress and inflammation, as well as activation of pro-survival pathway. 43 Consistently, we identified that YWPC mitigated cellular 45 The heart has high energy requirement and a high mitochondrial density, which is more susceptible to DOX-induced toxicity. 46 With the treatment of YWPC, we found great improvement in the disordered and swelled mitochondria induced by DOX. Researchers have confirmed that DOX treatment affects mitochondrial gene expression and suppresses cardiac mitochondrial metabolism and biogenesis, resulting in mitochondrial dependent apoptosis. 47 Here,
we found that YWPC reduced the level of DOX-induced mitochondria-mediated apoptosis of cardiac myocytes, with the up-regulation of Bcl-2 and down-regulation of Bax, and release of cytochrome C and cleaved caspase-3.
Cardiac fibrosis is the common feature of many cardiac pathophysiological conditions, and has been considered to be involved in cardiac stiffness and dysfunction in DOX-induced cardiotoxicity.
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In the present study, we found that co-administration with YWPC caused a remarkable inhibition of TGF-β1/smad3 pathway, reduction of ECM and mitigatory fibrosis in DOX-treated rats. TGF-β1/ smad3 pathway is considered to be the most potent and ubiquitous pro-fibrogenic cytokines that involved in the development of fibrosis. 15, 48 It also reported that DOX triggered fibrosis through α-SMA, Collagen I and III regulation. Consistently, we found the protein levels of Collagen I and α-SMA were dramatically increased in DOX-treated rats, indicating cardiac fibroblasts activation and ex- 54 On the contrary, using COOD-EA (a Nrf2 inducer)
as a positive control, our study confirmed that YWPC could active Nrf2 pathway in DOX-induced rats to inhibit the progress of cardiac fibrosis, in vivo. Taken together, our data supported the idea that YWPC could activate Nrf2 signalling pathway and attenuate the DOX-induced toxicity.
Although it is still unsure whether YWPC have the ability to reinforce the chemotherapeutic efficacy of DOX or have anti-cancer effects, the current study found that YWPC supplementation alleviated DOX-induced cardiac dysfunction, as well as migrated cardiac fibrosis, and discussed its potential mechanisms. However, our study had certain limitations. Firstly, YWPC used in this experiment are a mixture of different monomer components, and which one of them plays a protective role is still unclear. Besides, findings based on DOX-induced cardiotoxicity in SD rats could not fully represent the situations and pathology in human; thus, further validations in clinical study are needed in future study.
Collectively, our data showed that YWPC supplementation protects against oxidative stress, mitochondrial damage, fibrosis, hypertrophy and apoptosis, eventually improving cardiac function in DOX-treated rats. The cardioprotective role of YWPC is contributing from its ability to inhibit DOX-stimulated oxidative stress by augmenting the Nrf2 pathway. The results suggested that YWPC might be a promising novel therapeutic strategy to reduce DOX-induced cardiotoxicity.
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